Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.
about
Acute liver failure including acetaminophen overdoseMicroporous membrane-based liver tissue engineering for the reconstruction of three-dimensional functional liver tissues in vitroCell sources, liver support systems and liver tissue engineering: alternatives to liver transplantationPivotal preclinical trial of the spheroid reservoir bioartificial liverNew Phase of Growth for Xenogeneic-Based Bioartificial OrgansArtificial and bioartificial liver supportAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Self-assembling peptide nanofiber as a novel culture system for isolated porcine hepatocytes.Detoxification as a treatment goal in hepatic failure.Efficient large-scale generation of functional hepatocytes from mouse embryonic stem cells grown in a rotating bioreactor with exogenous growth factors and hormonesComparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs.Functional evaluation of a new bioartificial liver system in vitro and in vitroBioreactor technologies to support liver function in vitro.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Hepatic encephalopathy: from pathophysiology to treatment.SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failureEvaluation of the Hepa Wash® treatment in pigs with acute liver failure.A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study.Liver transplantation for Wilson disease.A new technique for primary hepatocyte expansion in vitroAn Update on Treatment of Drug-Induced Liver Injury.A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems.History of xenotransplantation.Acute liver failure: Summary of a workshopMachine perfusion enhances hepatocyte isolation yields from ischemic livers.The European artificial organ scene: present status.Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience.Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactorTechnology insight: liver support systems.Liver support systems: promise and reality.Scaffolds for liver tissue engineering.Recent investigations into pig antigen and anti-pig antibody expressionSorbent suspensions vs. sorbent columns for extracorporeal detoxification in hepatic failure.Bioartificial liver: its pros and cons.How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?Recent developments in acute liver failureImproved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes
P2860
Q24647134-91CB6342-02E3-4D07-9BE8-611D1E33E6F4Q26996192-4E5F6425-71C5-417F-A3A6-0043A54A0C7CQ27001113-E041DD68-D65A-43CF-BA8D-881FA3B8102BQ27309887-18888590-EE96-4A98-B987-A44AD5C9AD03Q28075442-20388D32-7161-46B0-8EAB-FB08132C76C7Q28237883-6BC79E1C-7315-49F8-84BF-FE5CBE80561AQ30234560-8763255B-C06D-4746-B1A6-33B42BF671FFQ30276550-152C9EA6-8589-4F76-A774-804FEF59F960Q30829886-5A490ECB-74D2-4D18-ABB7-29DB7E09034EQ33396573-C426D49B-490C-44FD-A18C-D9E9BADD60EDQ33745903-EDF0F2AC-6B87-4FE2-AF88-237D781FB60FQ33866914-0F21B4DD-46B5-4C4C-B078-F0C90FB9D504Q34013230-71CF4521-DDCB-4CA6-9679-4556B213E2B0Q34087508-8EBF820B-BD4E-4C79-AC20-34199EDA969DQ34122035-84EB7CDF-BEF6-40ED-9A15-999255B2052CQ34565090-50656DB2-7BEF-467B-8A07-C2673C12E2B6Q34569517-2E95DE7D-FB7C-4103-981E-A9C80D598FDCQ34629959-44E6C44A-4F0A-4F3A-A2AD-94BC71759F34Q34719069-A05BC9EC-8D34-4CF5-B664-EC33C78F9836Q35446580-68442AE1-6256-4D20-9E3F-41D7D402505EQ35559371-154CA9CF-242D-4A4B-A8B4-8B6234C6C6B8Q35736533-B6EDC273-139C-4E20-86B2-5CBECDEA2D2AQ35805123-29BF0237-DB03-432B-B425-1423E08EACCCQ35905999-AD9FA2C2-BE7B-404F-BEE6-FF8C5384A07DQ35913437-CEE2AFD1-881A-4BFB-B5B7-6374C1467794Q36031618-B2271A26-C08C-42B8-95CA-DE3D5BC33857Q36054934-CEB30D6B-AFD8-4BD6-8D81-F135907DF3DCQ36096087-EC4C815D-9C63-4446-BC6D-AA97BBC41C62Q36145893-A425DB71-C4A9-401B-8820-605C93BAFF72Q36154078-DC6ECDC5-301D-4FA2-B7A7-41F1C49C149CQ36190385-7DB4310C-69A9-48FB-A682-943359A32823Q36304257-D2FC66F2-3EDC-4CE0-BB70-FB6202FCACAAQ36335206-176F2D52-EB73-427C-9B1C-4A6F8187D3E8Q36344068-C3DE1AFE-91AA-4345-AAD8-F167A2D6AA32Q36386185-7752BD8E-C1EF-47AD-9899-9809881015C3Q36473235-2D46466F-7B5E-4B98-B336-CF1F3B335F7AQ36473242-A1321563-164D-465B-8BB6-887AD069FE53Q36492605-FB604A32-A6C8-49C8-9EC1-C8ADF2DA8891Q36551050-85A286EE-69BE-4066-A88C-7BA09A833427Q36559990-13014B16-C218-4222-A261-E4D858A323FB
P2860
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prospective, randomized, multi ...... treating acute liver failure.
@ast
Prospective, randomized, multi ...... treating acute liver failure.
@en
Prospective, randomized, multi ...... treating acute liver failure.
@nl
type
label
Prospective, randomized, multi ...... treating acute liver failure.
@ast
Prospective, randomized, multi ...... treating acute liver failure.
@en
Prospective, randomized, multi ...... treating acute liver failure.
@nl
prefLabel
Prospective, randomized, multi ...... treating acute liver failure.
@ast
Prospective, randomized, multi ...... treating acute liver failure.
@en
Prospective, randomized, multi ...... treating acute liver failure.
@nl
P2093
P2860
P50
P1433
P1476
Prospective, randomized, multi ...... n treating acute liver failure
@en
P2093
Achilles A Demetriou
Anthony C Stevens
Barry A Solomon
Bernard de Hemptinne
Brendan M McGuire
Christoph E Broelsch
Daniel Pratt
Elizabeth A Fagan
Gregory T Everson
Herold J Metselaar
P2860
P304
660-7; discussion 667-70
P356
10.1097/01.SLA.0000124298.74199.E5
P407
P577
2004-05-01T00:00:00Z